if there's a problem in the cost of drugs and cancer drugs, it's all the private oncology practices being purchased by hospital systems--DSH hospitals who then get a 50 percent break from the pharmaceutical companies on these expensive drugs.
Highlights the issue of hospital systems profiting from discounted cancer drugs.
Share & report
More from Chris Collins
I think that the belief that significant flexibilities or block grants or per capita caps would automatically mean less delivery of care ignores that economists on the right and left center of the aisle believe there's significant…
I think you owe it to put something like that up there or change the charter or get us to change it.
That's it's going to be one and done. That there is going to be one major vote that includes some of the changes that the House Freedom Caucus demanded and got.
Other voices in this conversation
